U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07237516) titled 'Zymfentra (Infliximab-dyyb) REal World Cohort STudy' on Nov. 03.
Brief Summary: The goal of this observational study is to learn about how effective Zymfentra (IFX=dyyb) is when treating patients with Crohn's disease (CD) and ulcerative colitis (UC) Does Zymfentra lead to a reduction in symptoms at intervals throughout one year? Participants being prescribed Zymfentra (IFX-dyyb as part of their regular medical care for CD or UC will answer online survey questions about their bowel habits for 1 year.
Study Start Date: Nov. 24
Study Type: OBSERVATIONAL
Condition:
Ulcerative Colitis (UC)
Crohn's Disease (CD)
Indeterminate Colitis
I...